	Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform than patients who received treatment normally. The AI platform used software algorithms on smartphones to confirm patient identity, medication and medication ingestion.

News

Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform.